… ProQR Announces Results for the First Quarter of 2016 LEIDEN, … pipeline", said Daniel de Boer, Chief Executive Officer of ProQR. “This quarter we organized an inaugural R&D Day where we, along with key opinion leaders presented …
… ProQR Announces Participation in Upcoming Kempen Life … & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … 2021 Thematic Virtual Series on April 28, 2021. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR to Present at Two Investor Conferences in October … Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … will be held from October 2-4, 2019 in New York, NY. ProQR will present on Wednesday, October 2, 2019 at 3:35 pm …
… ProQR Announces Results for the Third Quarter of 2016 LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel de Boer, Chief Executive Officer of ProQR “I’m proud of the team that has designed and executed …
… ProQR to Present at Three Scientific Conferences in April … and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … K. Koenekoop, MD, PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and …
… ProQR to Present at the Chardan Genetic Medicines Conference … LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Presenter : Gerard Platenburg, chief innovation officer of ProQR Presentation : Tuesday, October 9, 2018 at 8:00 am ET …
… ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … a long-term collaborator of ProQR and a valued member of ProQR’s Scientific Advisory Board, where he has played an …